Recombinant human PTH 1-34 (Forteo): An anabolic drug for osteoporosis

Article Type
Changed
Thu, 11/15/2018 - 07:55
Display Headline
Recombinant human PTH 1-34 (Forteo): An anabolic drug for osteoporosis
Article PDF
Author and Disclosure Information

Chad Deal, MD
Head, Center for Osteoporosis and Metabolic Bone Disease, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

James Gideon, MD, PhD
Blanchard Valley Medical Associates, Findlay, OH

Address: Chad Deal, MD, Department of Rheumatic and Immunologic Disease, A51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Deal has indicated that he serves as a consultant for and is on the speaker’s bureau of Eli Lilly and Company.

Issue
Cleveland Clinic Journal of Medicine - 70(7)
Publications
Topics
Page Number
585-586, 589-590, 592-594, 597-598, 600-601
Sections
Author and Disclosure Information

Chad Deal, MD
Head, Center for Osteoporosis and Metabolic Bone Disease, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

James Gideon, MD, PhD
Blanchard Valley Medical Associates, Findlay, OH

Address: Chad Deal, MD, Department of Rheumatic and Immunologic Disease, A51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Deal has indicated that he serves as a consultant for and is on the speaker’s bureau of Eli Lilly and Company.

Author and Disclosure Information

Chad Deal, MD
Head, Center for Osteoporosis and Metabolic Bone Disease, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

James Gideon, MD, PhD
Blanchard Valley Medical Associates, Findlay, OH

Address: Chad Deal, MD, Department of Rheumatic and Immunologic Disease, A51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Deal has indicated that he serves as a consultant for and is on the speaker’s bureau of Eli Lilly and Company.

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 70(7)
Issue
Cleveland Clinic Journal of Medicine - 70(7)
Page Number
585-586, 589-590, 592-594, 597-598, 600-601
Page Number
585-586, 589-590, 592-594, 597-598, 600-601
Publications
Publications
Topics
Article Type
Display Headline
Recombinant human PTH 1-34 (Forteo): An anabolic drug for osteoporosis
Display Headline
Recombinant human PTH 1-34 (Forteo): An anabolic drug for osteoporosis
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Can calcium and vitamin D supplementation adequately treat most patients with osteoporosis?

Article Type
Changed
Fri, 02/15/2019 - 08:40
Display Headline
Can calcium and vitamin D supplementation adequately treat most patients with osteoporosis?
Article PDF
Author and Disclosure Information

Chad Deal, MD
Department of Rheumatic and Immunologic Disease, Cleveland Clinic

Address: Chad Deal, MD, Department of Rheumatic and Immunologic Disease, A50,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Issue
Cleveland Clinic Journal of Medicine - 67(10)
Publications
Topics
Page Number
696, 698
Sections
Author and Disclosure Information

Chad Deal, MD
Department of Rheumatic and Immunologic Disease, Cleveland Clinic

Address: Chad Deal, MD, Department of Rheumatic and Immunologic Disease, A50,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Author and Disclosure Information

Chad Deal, MD
Department of Rheumatic and Immunologic Disease, Cleveland Clinic

Address: Chad Deal, MD, Department of Rheumatic and Immunologic Disease, A50,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 67(10)
Issue
Cleveland Clinic Journal of Medicine - 67(10)
Page Number
696, 698
Page Number
696, 698
Publications
Publications
Topics
Article Type
Display Headline
Can calcium and vitamin D supplementation adequately treat most patients with osteoporosis?
Display Headline
Can calcium and vitamin D supplementation adequately treat most patients with osteoporosis?
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media